CoChat

Determinants of maternal and neonatal PFAS concentrations: a review

Open access
McAdam, Jordan, Bell, Erin M. · 2023 · Environmental Health
Cited by 91

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Per- and polyfluoroalkyl substances (PFAS) are used for their properties such as stain and water resistance. The substances have been associated with adverse health outcomes in both pregnant mothers and infants, including pre-eclampsia and low birthweight. A growing body of research suggests that PFAS are transferred from mother to fetus through the placenta, leading to in utero exposure. A systematic review was performed using the PubMed database to search for studies evaluating determinants of PFAS concentrations in blood matrices of pregnant mothers and neonates shortly after birth. Studies were included in this review if an observational study design was utilized, exposure to at least one PFAS analyte was measured, PFAS were measured in maternal or neonatal matrices, at least one determinant of PFAS concentrations was assessed, and results such as beta estimates were provided. We identified 35 studies for inclusion in the review and evaluated the PFAS and determinant relationships among the factors collected in these studies. Parity, breastfeeding history, maternal race and country of origin, and household income had the strongest and most consistent evidence to support their roles as determinants of certain PFAS concentrations in pregnant mothers. Reported study findings on smoking status, alcohol consumption, and pre-pregnancy body mass index (BMI) suggest that these factors are not important determinants of PFAS concentrations in pregnant mothers or neonates. Further study into informative factors such as consumer product use, detailed dietary information, and consumed water sources as potential determinants of maternal or neonatal PFAS concentrations is needed. Research on determinants of maternal or neonatal PFAS concentrations is critical to estimate past PFAS exposure, build improved exposure models, and further our understanding on dose–response relationships, which can influence epidemiological studies and risk assessment evaluations. Given the potential for adverse outcomes in pregnant mothers and neonates exposed to PFAS, it is important to identify and understand determinants of maternal and neonatal PFAS concentrations to better implement public health interventions in these populations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12940-023-00992-x

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Research works printed but not linked: 159

  1. Abraham K, Monien BH. Transdermal absorption of 13C4-perfluorooctanoic acid (13C4-PFOA) from a sunscreen in a male volunteer – What could be the contribution of cosmetics to the internal exposure of perfluoroalkyl substances (PFAS)? Environ Int. 2022;169: 107549. · DOI
  2. Harris KJ, et al. Targeted and suspect screening of per- and polyfluoroalkyl substances in cosmetics and personal care products. Environ Sci Technol. 2022;56(20):14594–604. · DOI
  3. Jain RB. Contribution of diet and other factors to the levels of selected polyfluorinated compounds: data from NHANES 2003–2008. Int J Hyg Environ Health. 2014;217(1):52–61. · DOI
  4. Kjølholt J, Jensen A, Warming M. Short-chain Polyfluoroalkyl Substances (PFAS): a literature review of information on human health effects and environmental fate and effect aspects of short-chain PFAS. Denmark: Danish Ministry of the Environment; 2015. Project no. 1707. https://www2.mst.dk/Udgiv/publications/2015/05/978-87-93352-15-5.pdf.
  5. Pelch KE, et al. PFAS health effects database: Protocol for a systematic evidence map. Environ Int. 2019;130: 104851. · DOI · Paper page
  6. Woodlief T, et al. Immunotoxicity of Per- and Polyfluoroalkyl Substances: Insights into Short-Chain PFAS Exposure. Toxics. 2021;9. https://doi.org/10.3390/toxics9050100. · DOI
  7. Prevedouros K, et al. Sources, fate and transport of perfluorocarboxylates. Environ Sci Technol. 2006;40(1):32–44. · DOI · Paper page
  8. Dunder L, et al. Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 years. Environ Res. 2022;211: 112903. · DOI
  9. Li Y, et al. Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water. Environ Health. 2020;19(1):33. · DOI · Paper page
  10. Lin P-ID, et al. Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults—longitudinal analysis of the diabetes prevention program outcomes study. Environ Int. 2019;129:343–53. · DOI · Paper page
  11. Liu J-J, et al. Per- and perfluoroalkyl substances alternatives, mixtures and liver function in adults: a community-based population study in China. Environ Int. 2022;163: 107179. · DOI · Paper page
  12. Salihovic S, et al. Changes in markers of liver function in relation to changes in perfluoroalkyl substances - A longitudinal study. Environ Int. 2018;117:196–203. · DOI
  13. Averina M, et al. Exposure to perfluoroalkyl substances (PFAS) and dyslipidemia, hypertension and obesity in adolescents The Fit Futures study. Environ Res. 2021;195: 110740. · DOI · Paper page
  14. Pitter G, et al. Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults. Environ Health. 2020;19(1):102. · DOI
  15. Fan X, et al. Global Exposure to Per- and Polyfluoroalkyl Substances and Associated Burden of Low Birthweight. Environ Sci Technol. 2022;56(7):4282–94. · DOI
  16. Wikström S, et al. Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight. Pediatr Res. 2020;87(6):1093–9. · DOI · Paper page
  17. Gump BB, et al. Perfluorochemical (PFC) exposure in children: associations with impaired response inhibition. Environ Sci Technol. 2011;45(19):8151–9. · DOI · Paper page
  18. Hoffman K, et al. Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in US children 12–15 years of age. Environ Health Perspect. 2010;118(12):1762–7. · DOI · Paper page
  19. Høyer BB, et al. Pregnancy serum concentrations of perfluorinated alkyl substances and offspring behaviour and motor development at age 5–9 years–a prospective study. Environ Health. 2015;14(1):1–11. · DOI · Paper page
  20. Vuong AM, et al. Prenatal polybrominated diphenyl ether and perfluoroalkyl substance exposures and executive function in school-age children. Environ Res. 2016;147:556–64. · DOI
  21. Braun JM, et al. Prenatal perfluoroalkyl substance exposure and child adiposity at 8 years of age: the HOME study. Obesity. 2016;24(1):231–7. · DOI · Paper page
  22. Høyer BB, et al. Anthropometry in 5-to 9-year-old Greenlandic and Ukrainian children in relation to prenatal exposure to perfluorinated alkyl substances. Environ Health Perspect. 2015;123(8):841–6. · DOI · Paper page
  23. Mora AM, et al. Prenatal exposure to perfluoroalkyl substances and adiposity in early and mid-childhood. Environ Health Perspect. 2017;125(3):467–73. · DOI · Paper page
  24. Fei C, et al. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect. 2007;115(11):1677–82. · DOI · Paper page
  25. Matilla-Santander N, et al. Exposure to perfluoroalkyl substances and metabolic outcomes in pregnant women: evidence from the Spanish INMA birth cohorts. Environ Health Perspect. 2017;125(11): 117004. · DOI · Paper page
  26. Pan Y, et al. Novel chlorinated polyfluorinated ether sulfonates and legacy per-/polyfluoroalkyl substances: placental transfer and relationship with serum albumin and glomerular filtration rate. Environ Sci Technol. 2017;51(1):634–44. · DOI · Paper page
  27. Wang Y, et al. Efficiency of maternal-fetal transfer of perfluoroalkyl and polyfluoroalkyl substances. Environ Sci Pollut Res Int. 2019;26(3):2691–8. · DOI
  28. Cai D, et al. High trans-placental transfer of perfluoroalkyl substances alternatives in the matched maternal-cord blood serum: Evidence from a birth cohort study. Sci Total Environ. 2020;705: 135885. · DOI · Paper page
  29. Eryasa B, et al. Physico-chemical properties and gestational diabetes predict transplacental transfer and partitioning of perfluoroalkyl substances. Environ Int. 2019;130: 104874. · DOI · Paper page
  30. Kato K, et al. Changes in serum concentrations of maternal poly-and perfluoroalkyl substances over the course of pregnancy and predictors of exposure in a multiethnic cohort of Cincinnati, Ohio pregnant women during 2003–2006. Environ Sci Technol. 2014;48(16):9600–8. · DOI · Paper page
  31. Li Y, et al. Transplacental transfer of per-and polyfluoroalkyl substances identified in paired maternal and cord sera using suspect and nontarget screening. Environ Sci Technol. 2020;54(6):3407–16. · DOI · Paper page
  32. Liu J, et al. Comparison on gestation and lactation exposure of perfluorinated compounds for newborns. Environ Int. 2011;37(7):1206–12. · DOI · Paper page
  33. Wang Y, et al. Efficiency of maternal-fetal transfer of perfluoroalkyl and polyfluoroalkyl substances. Environ Sci Pollut Res. 2019;26(3):2691–8. · DOI
  34. Zhang T, et al. Distribution of poly-and perfluoroalkyl substances in matched samples from pregnant women and carbon chain length related maternal transfer. Environ Sci Technol. 2013;47(14):7974–81. · DOI · Paper page
  35. Barr DB, et al. The use of dried blood spots for characterizing children’s exposure to organic environmental chemicals. Environ Res. 2021;195: 110796. · DOI
  36. Rothwell E, et al. Secondary research uses of residual newborn screening dried bloodspots: a scoping review. Genet Med. 2019;21(7):1469–75. · DOI
  37. Brochot C, et al. Prediction of maternal and foetal exposures to perfluoroalkyl compounds in a Spanish birth cohort using toxicokinetic modelling. Toxicol Appl Pharmacol. 2019;379: 114640. · DOI
  38. Chou WC, Lin Z. Development of a Gestational and Lactational Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctane Sulfonate (PFOS) in Rats and Humans and Its Implications in the Derivation of Health-Based Toxicity Values. Environ Health Perspect. 2021;129(3):37004. · DOI
  39. Verner M-A, et al. A Simple Pharmacokinetic Model of Prenatal and Postnatal Exposure to Perfluoroalkyl Substances (PFASs). Environ Sci Technol. 2016;50(2):978–86. · DOI
  40. Rogers RD, Reh CM, Breysse P. Advancing per- and polyfluoroalkyl substances (PFAS) research: an overview of ATSDR and NCEH activities and recommendations. J Eposure Sci Environ Epidemiol. 2021;31(6):961–71. · DOI
  41. Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097. · DOI · Paper page
  42. Taris TW, Kompier M. Challenges in longitudinal designs in occupational health psychology. Scand J Work Environ Health. 2003;1:1–4. · DOI · Paper page
  43. Frisbee SJ, et al. The C8 health project: design, methods, and participants. Environ Health Perspect. 2009;117(12):1873–82. · DOI · Paper page
  44. Caron-Beaudoin É, et al. Perfluoroalkyl acids in pregnant women from Nunavik (Quebec, Canada): Trends in exposure and associations with country foods consumption. Environ Int. 2020;145: 106169. · DOI
  45. Fisher M, et al. Concentrations of persistent organic pollutants in maternal and cord blood from the maternal-infant research on environmental chemicals (MIREC) cohort study. Environ Health. 2016;15(1):59. · DOI · Paper page
  46. Lewin A, et al. Univariate predictors of maternal concentrations of environmental chemicals: The MIREC study. Int J Hyg Environ Health. 2017;220(2 Pt A):77–85. · DOI
  47. Lien GW, et al. Neonatal-maternal factors and perfluoroalkyl substances in cord blood. Chemosphere. 2013;92(7):843–50. · DOI
  48. Berg V, et al. Maternal serum concentrations of per- and polyfluoroalkyl substances and their predictors in years with reduced production and use. Environ Int. 2014;69:58–66. · DOI
  49. Brantsæter AL, et al. Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women. Environ Int. 2013;54:74–84. · DOI · Paper page
  50. Lauritzen HB, et al. Factors associated with maternal serum levels of Perfluoroalkyl substances and organochlorines: a descriptive study of parous women in Norway and Sweden. PLoS ONE. 2016;11(11): e0166127. · DOI · Paper page
  51. Papadopoulou E, et al. Reliability of perfluoroalkyl substances in plasma of 100 women in two consecutive pregnancies. Environ Res. 2015;140:421–9. · DOI
  52. Rush EL, et al. Oral contraceptive use as a determinant of plasma concentrations of perfluoroalkyl substances among women in the Norwegian Mother and Child Cohort (MoBa) study. Environ Int. 2018;112:156–64. · DOI · Paper page
  53. Singer AB, et al. Menstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study). Environ Res. 2018;166:78–85. · DOI · Paper page
  54. Marks KJ, et al. Maternal dietary patterns during pregnancy and exposure to persistent endocrine disrupting chemicals in two European birth cohorts. Environ Adv. 2021;6. Article 100130. · DOI
  55. Ode A, et al. Determinants of maternal and fetal exposure and temporal trends of perfluorinated compounds. Environ Sci Pollut Res Int. 2013;20(11):7970–8. · DOI
  56. Shu H, et al. Temporal trends and predictors of perfluoroalkyl substances serum levels in Swedish pregnant women in the SELMA study. PLoS ONE. 2018;13(12): e0209255. · DOI
  57. Chang CJ, et al. Serum per- and polyfluoroalkyl substance (PFAS) concentrations and predictors of exposure among pregnant African American women in the Atlanta area. Georgia Environ Res. 2021;198: 110445. · DOI
  58. Kalloo G, et al. Profiles and predictors of environmental chemical mixture exposure among pregnant women: the health outcomes and measures of the environment study. Environ Sci Technol. 2018;52(17):10104–13. · DOI
  59. Kingsley SL, et al. Variability and predictors of serum perfluoroalkyl substance concentrations during pregnancy and early childhood. Environ Res. 2018;165:247–57. · DOI
  60. Mehta SS, et al. Associations between sociodemographic characteristics and exposures to PBDEs, OH-PBDEs, PCBs, and PFASs in a diverse, overweight population of pregnant women. J Eposure Sci Environ Epidemiol. 2020;30(1):42–55. · DOI
  61. Sagiv SK, et al. Sociodemographic and perinatal predictors of early pregnancy per- and Polyfluoroalkyl Substance (PFAS) concentrations. Environ Sci Technol. 2015;49(19):11849–58. · DOI · Paper page
  62. Spratlen MJ, et al. Cord blood perfluoroalkyl substances in mothers exposed to the World Trade Center disaster during pregnancy. Environ Pollut. 2019;246:482–90. · DOI
  63. Goin DE, et al. Disparities in chemical exposures among pregnant women and neonates by socioeconomic and demographic characteristics: a nontargeted approach. Environ Res. 2022;215: 114158. · DOI
  64. Richterová D, et al. Determinants of prenatal exposure to perfluoroalkyl substances in the Slovak birth cohort. Environ Int. 2018;121(Pt 2):1304–10. · DOI
  65. Tsai MS, et al. Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health. Int J Environ Res Public Health. 2018;15(5):99. · DOI
  66. Manzano-Salgado CB, et al. Variability of perfluoroalkyl substance concentrations in pregnant women by socio-demographic and dietary factors in a Spanish birth cohort. Environ Int. 2016;92–93:357–65. · DOI
  67. Yamada A, et al. Dietary exposure to perfluoroalkyl acids of specific French adult sub-populations: high seafood consumers, high freshwater fish consumers and pregnant women. Sci Total Environ. 2014;491–492:170–5. · DOI
  68. Long M, et al. Food intake and serum persistent organic pollutants in the Greenlandic pregnant women: the ACCEPT sub-study. Sci Total Environ. 2015;529:198–212. · DOI
  69. Han W, et al. Perfluoroalkyl and polyfluoroalkyl substances in matched parental and cord serum in Shandong. China Environ Int. 2018;116:206–13. · DOI
  70. Tian Y, et al. Determinants of plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances in pregnant women from a birth cohort in Shanghai. China Environ Int. 2018;119:165–73. · DOI
  71. Xu C, et al. Prenatal exposure to chlorinated polyfluoroalkyl ether sulfonic acids and perfluoroalkyl acids: Potential role of maternal determinants and associations with birth outcomes. J Hazard Mater. 2019;380: 120867. · DOI · Paper page
  72. Yang J, et al. Factors associated with exposure of pregnant women to perfluoroalkyl acids in North China and health risk assessment. Sci Total Environ. 2019;655:356–62. · DOI
  73. Jia J, et al. Perfluoroalkyl and polyfluoroalkyl substances in cord serum of newborns and their potential factors. Chemosphere. 2023;313: 137525. · DOI
  74. Colles A, et al. Perfluorinated substances in the Flemish population (Belgium): levels and determinants of variability in exposure. Chemosphere. 2020;242: 125250. · DOI
  75. Espindola Santos AS, et al. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonic acid in pregnant women: maternal predictors and associations with birth outcomes in the PIPA Project. J Obstet Gynaecol Res. 2021;47(9):3107–18. · DOI
  76. Bjerregaard-Olesen C, et al. Determinants of serum levels of perfluorinated alkyl acids in Danish pregnant women. Int J Hyg Environ Health. 2016;219(8):867–75. · DOI
  77. Fábelová L, et al. PFAS levels and exposure determinants in sensitive population groups. Chemosphere. 2023;313: 137530. · DOI
  78. Papadopoulou E, et al. Diet as a source of exposure to environmental contaminants for pregnant women and children from six european countries. Environ Health Perspect. 2019;127(10): 107005. · DOI · Paper page
  79. Ehresman DJ, et al. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environ Res. 2007;103(2):176–84. · DOI · Paper page
  80. Nations, U. World Population Prospects 2019. New York: Department of Economic and Social Affairs, Population Division Online; 2019. · DOI · Paper page
  81. Salvalaglio M, Muscionico I, Cavallotti C. Determination of Energies and Sites of Binding of PFOA and PFOS to Human Serum Albumin. J Phys Chem B. 2010;114(46):14860–74. · DOI
  82. Weaving G, Batstone GF, Jones RG. Age and sex variation in serum albumin concentration: an observational study. Ann Clin Biochem. 2016;53(Pt 1):106–11. · DOI · Paper page
  83. Denic A, Glassock RJ, Rule AD. Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis. 2016;23(1):19–28. · DOI · Paper page
  84. Musso C.G, Oreopoulos D.G. Aging and physiological changes of the kidneys including changes in glomerular filtration rate. Nephron Physiol. 2011;119(Suppl. 1):1–5. · DOI · Paper page
  85. Verner M-A, et al. Associations of perfluoroalkyl substances (PFAS) with lower birth weight: an evaluation of potential confounding by glomerular filtration rate using a physiologically based pharmacokinetic model (PBPK). Environ Health Perspect. 2015;123(12):1317–24. · DOI · Paper page
  86. Metge C, et al. The population's use of pharmaceuticals. Med Care. 1999;37:JS42–59. · DOI
  87. Reinders I, Visser M, Schaap L. Body weight and body composition in old age and their relationship with frailty. Curr Opin Clin Nutr Metab Care. 2017;20(1):11–5. · DOI
  88. Christensen KY, et al. Perfluoroalkyl substances and fish consumption. Environ Res. 2017;154:145–51. · DOI · Paper page
  89. Ducatman A, Luster M, Fletcher T. Perfluoroalkyl substance excretion: Effects of organic anion-inhibiting and resin-binding drugs in a community setting. Environ Toxicol Pharmacol. 2021;85: 103650. · DOI · Paper page
  90. Quinn CL, Wania F. Understanding differences in the body burden-age relationships of bioaccumulating contaminants based on population cross sections versus individuals. Environ Health Perspect. 2012;120(4):554–9. · DOI · Paper page
  91. Cariou R, et al. Perfluoroalkyl acid (PFAA) levels and profiles in breast milk, maternal and cord serum of French women and their newborns. Environ Int. 2015;84:71–81. · DOI · Paper page
  92. Lorber M, et al. The effect of ongoing blood loss on human serum concentrations of perfluorinated acids. Chemosphere. 2015;118:170–7. · DOI
  93. Eriksen KT, et al. Determinants of plasma PFOA and PFOS levels among 652 Danish men. Environ Sci Technol. 2011;45(19):8137–43. · DOI · Paper page
  94. Park SK, et al. Determinants of per- and polyfluoroalkyl substances (PFAS) in midlife women: evidence of racial/ethnic and geographic differences in PFAS exposure. Environ Res. 2019;175:186–99. · DOI · Paper page
  95. Bottoni A, Cannella C, Del Balzo V. Lifestyle and dietary differences in smokers and non-smokers from an Italian employee population. Public Health. 1997;111(3):161–4. · doi:10.1016/s0033-3506(97)00576-3
  96. Ma J, Betts NM, Hampl JS. Clustering of lifestyle behaviors: the relationship between cigarette smoking, alcohol consumption, and dietary intake. Am J Health Promot. 2000;15(2):107–17. · DOI
  97. Thornton A, Lee P, Fry J. Differences between smokers, ex-smokers, passive smokers and non-smokers. J Clin Epidemiol. 1994;47(10):1143–62. · DOI
  98. Halldorsson TI, et al. Dietary predictors of perfluorinated chemicals: a study from the Danish National Birth Cohort. Environ Sci Technol. 2008;42(23):8971–7. · DOI
  99. Ford RP, et al. Smoking during pregnancy: how reliable are maternal self reports in New Zealand? J Epidemiol Community Health. 1997;51(3):246–51. · DOI · Paper page
  100. Klebanoff MA, et al. Accuracy of self-reported cigarette smoking among pregnant women in the 1990s. Paediatr Perinat Epidemiol. 2001;15(2):140–3. · DOI · Paper page
  101. Lindqvist R, et al. Smoking during pregnancy: comparison of self-reports and cotinine levels in 496 women. Acta Obstet Gynecol Scand. 2002;81(3):240–4. · DOI · Paper page
  102. Russell T, Crawford M, Woodby L. Measurements for active cigarette smoke exposure in prevalence and cessation studies: why simply asking pregnant women isn’t enough. Nicotine Tob Res. 2004;6(Suppl 2):S141–51. · DOI · Paper page
  103. Hölzer J, et al. Biomonitoring of perfluorinated compounds in children and adults exposed to perfluorooctanoate-contaminated drinking water. Environ Health Perspect. 2008;116(5):651–7. · DOI · Paper page
  104. Ji K, et al. Serum concentrations of major perfluorinated compounds among the general population in Korea: dietary sources and potential impact on thyroid hormones. Environ Int. 2012;45:78–85. · DOI
  105. Rylander C, et al. Dietary predictors and plasma concentrations of perfluorinated compounds in a coastal population from northern Norway. J Environ Public Health. 2009;2009: 268219. · DOI
  106. Maestri L, et al. Determination of perfluorooctanoic acid and perfluorooctanesulfonate in human tissues by liquid chromatography/single quadrupole mass spectrometry. Rapid Commun Mass Spectrom. 2006;20(18):2728–34. · DOI · Paper page
  107. Nadal A, et al. Endocrine-disrupting chemicals and the regulation of energy balance. Nat Rev Endocrinol. 2017;13(9):536–46. · DOI · Paper page
  108. Liu P, et al. Perfluorooctanoic acid (PFOA) exposure in early life increases risk of childhood adiposity: a meta-analysis of prospective cohort studies. Int J Environ Res Public Health. 2018;15(10):2070. · DOI
  109. Braun JM. Early-life exposure to EDCs: role in childhood obesity and neurodevelopment. Nat Rev Endocrinol. 2017;13(3):161–73. · DOI · Paper page
  110. Zhang L, et al. Structure-dependent binding and activation of perfluorinated compounds on human peroxisome proliferator-activated receptor γ. Toxicol Appl Pharmacol. 2014;279(3):275–83. · DOI
  111. Lopez-Espinosa M-J, et al. Thyroid function and perfluoroalkyl acids in children living near a chemical plant. Environ Health Perspect. 2012;120(7):1036–41. · DOI · Paper page
  112. Melzer D, et al. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the US National Health and Nutrition Examination Survey. Environ Health Perspect. 2010;118(5):686–92. · DOI · Paper page
  113. Winquist A, Steenland K. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts. Epidemiol. 2014;25(2):255–64. · DOI · Paper page
  114. Hattori A, Sturm R. The obesity epidemic and changes in self-report biases in BMI. Obesity (Silver Spring). 2013;21(4):856–60. · DOI
  115. Hsiao H, et al. Comparison of measured and self-reported anthropometric information among firefighters: implications and applications. Ergonomics. 2014;57(12):1886–97. · DOI
  116. Merrill RM, Richardson JS. Validity of self-reported height, weight, and body mass index: findings from the National Health and Nutrition Examination Survey, 2001–2006. Prev Chronic Dis. 2009;6(4):A121.
  117. Olfert MD, et al. Self-Reported vs. Measured Height, Weight, and BMI in Young Adults. Int J Environ Res Public Health. 2018;15(10). Article number 2216. · DOI · Paper page
  118. Engstrom JL, et al. Accuracy of self-reported height and weight in women: an integrative review of the literature. J Midwifery Womens Health. 2003;48(5):338–45. · DOI · Paper page
  119. Griebeler ML, et al. Self-reported versus measured height and weight in Hispanic and non-Hispanic menopausal women. J Womens Health (Larchmt). 2011;20(4):599–604. · DOI
  120. Ali SM, Lindström M. Socioeconomic, psychosocial, behavioural, and psychological determinants of BMI among young women: differing patterns for underweight and overweight/obesity. Eur J Pub Health. 2006;16(3):324–30. · DOI · Paper page
  121. Hill JO, Melanson EL. Overview of the determinants of overweight and obesity: current evidence and research issues. Med Sci Sports Exerc. 1999;31(11 Suppl):S515–21. · DOI · Paper page
  122. Oakes JM, Rossi PH. The measurement of SES in health research: current practice and steps toward a new approach. Soc Sci Med. 2003;56(4):769–84. · DOI · Paper page
  123. Sjogren P, et al. Circulating levels of perfluoroalkyl substances are associated with dietary patterns – A cross sectional study in elderly Swedish men and women. Environ Res. 2016;150:59–65. · DOI
  124. Alvik A, et al. Alcohol consumption before and during pregnancy comparing concurrent and retrospective reports. Alcohol Clin Exp Res. 2006;30(3):510–5. · DOI · Paper page
  125. Muennig P, et al. Blood and urine levels of long half-life toxicants by nativity among immigrants to the United States. Sci Total Environ. 2011;412–413:109–13. · DOI
  126. LaKind JS, et al. Current breast milk PFAS levels in the United States and Canada: After All This Time, Why Don’t We Know More? Environ Health Perspect. 2022;130(2):25002. · DOI
  127. Serrano L, et al. Concentrations of perfluoroalkyl substances in donor breast milk in Southern Spain and their potential determinants. Int J Hyg Environ Health. 2021;236: 113796. · DOI · Paper page
  128. Zheng G, et al. Per- and Polyfluoroalkyl Substances (PFAS) in Breast Milk: concerning trends for Current-Use PFAS. Environ Sci Technol. 2021;55(11):7510–20. · DOI · Paper page
  129. Thomsen C, et al. Changes in concentrations of perfluorinated compounds, polybrominated diphenyl ethers, and polychlorinated biphenyls in Norwegian breast-milk during twelve months of lactation. Environ Sci Technol. 2010;44(24):9550–6. · DOI
  130. Zheng P, et al. Prenatal and postnatal exposure to emerging and legacy per-/polyfluoroalkyl substances: Levels and transfer in maternal serum, cord serum, and breast milk. Sci Total Environ. 2022;812: 152446. · DOI
  131. Pinney SM, et al. Serum biomarkers of polyfluoroalkyl compound exposure in young girls in Greater Cincinnati and the San Francisco Bay Area, USA. Environ Pollut. 2014;184:327–34. · DOI
  132. Agostoni C, et al. Breast-feeding: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2009;49(1):112–25. · DOI · Paper page
  133. LaKind JS, et al. Per- and polyfluoroalkyl substances (PFAS) in breast milk and infant formula: a global issue. Environ Res. 2023;219: 115042. · DOI · Paper page
  134. Denys S, et al. Is the fresh water fish consumption a significant determinant of the internal exposure to perfluoroalkylated substances (PFAS)? Toxicol Lett. 2014;231(2):233–8. · DOI
  135. Lando AM, Fein SB, Choinière CJ. Awareness of methylmercury in fish and fish consumption among pregnant and postpartum women and women of childbearing age in the United States. Environ Res. 2012;116:85–92. · doi:10.1016/j.envres.2012.04.002
  136. Coecke S, et al. Toxicokinetics as a key to the integrated toxicity risk assessment based primarily on non-animal approaches. Toxicol In Vitro. 2013;27(5):1570–7. · DOI
  137. Gützkow KB, et al. Placental transfer of perfluorinated compounds is selective–a Norwegian Mother and Child sub-cohort study. Int J Hyg Environ Health. 2012;215(2):216–9. · DOI · Paper page
  138. Qi W, et al. Per- and Polyfluoroalkyl substances and obesity, type 2 diabetes and non-alcoholic fatty liver disease: a review of epidemiologic findings. Toxicol Environ Chem. 2020;102(1–4):1–36. · DOI
  139. Augustsson A, et al. Consumption of freshwater fish: a variable but significant risk factor for PFOS exposure. Environ Res. 2021;192: 110284. · DOI
  140. Kramer MS. Cross-Sectional Studies, in Clinical Epidemiology and Biostatistics: A Primer for Clinical Investigators and Decision-Makers, M.S. Kramer, Editor. Berlin, Heidelberg: Springer Berlin Heidelberg; 1988. p. 113–117. · DOI
  141. Chavance M, Dellatolas G, Lellouch J. Correlated nondifferential misclassifications of disease and exposure: application to a cross-sectional study of the relation between handedness and immune disorders. Int J Epidemiol. 1992;21(3):537–46. · doi:10.1093/ije/21.3.537
  142. Ghassabian A, et al. Concentrations of perfluoroalkyl substances and bisphenol A in newborn dried blood spots and the association with child behavior. Environ Pollut. 2018;243(Pt B):1629–36. · DOI
  143. Jager KJ, et al. Where to look for the most frequent biases? Nephrology (Carlton). 2020;25(6):435–41. · DOI · Paper page
  144. Emmett EA, et al. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med. 2006;48(8):759–70. · DOI · Paper page
  145. Yu CH, et al. Biomonitoring: a tool to assess PFNA body burdens and evaluate the effectiveness of drinking water intervention for communities in New Jersey. Int J Hyg Environ Health. 2021;235: 113757. · DOI
  146. Fenton SE, et al. Per- and Polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research. Environ Toxicol Chem. 2021;40(3):606–30. · DOI · Paper page
  147. Sagiv SK, et al. Early-pregnancy plasma concentrations of Perfluoroalkyl substances and birth outcomes in project viva: confounded by pregnancy hemodynamics? Am J Epidemiol. 2018;187(4):793–802. · DOI · Paper page
  148. Steenland K, Barry V, Savitz D. Serum Perfluorooctanoic acid and birthweight: an updated meta-analysis with bias analysis. Epidemiology. 2018;29(6):765–76. · DOI
  149. Nair AS, et al. Demographic and exposure characteristics as predictors of serum per- and polyfluoroalkyl substances (PFASs) levels - A community-level biomonitoring project in Pennsylvania. Int J Hyg Environ Health. 2021;231: 113631. · DOI
  150. Barton KE, et al. Sociodemographic and behavioral determinants of serum concentrations of per- and polyfluoroalkyl substances in a community highly exposed to aqueous film-forming foam contaminants in drinking water. Int J Hyg Environ Health. 2020;223(1):256–66. · DOI · Paper page
  151. Richterová D, et al. PFAS levels and determinants of variability in exposure in European teenagers - Results from the HBM4EU aligned studies (2014–2021). Int J Hyg Environ Health. 2023;247: 114057. · DOI
  152. Eick SM, et al. Dietary predictors of prenatal per- and poly-fluoroalkyl substances exposure. J Expo Sci Environ Epidemiol. 2023;33(1):32–9. · DOI · Paper page
  153. Wattigney WA, et al. Biomonitoring of per- and polyfluoroalkyl substances in minority angler communities in central New York State. Environ Res. 2022;204(Pt C): 112309. · DOI
  154. Timmermann A, et al. Per- and Polyfluoroalkyl substances and breastfeeding as a vulnerable function: a systematic review of epidemiological studies. Toxics. 2023;11(4):325. · DOI
  155. Birru RL, et al. A pathway level analysis of PFAS exposure and risk of gestational diabetes mellitus. Environ Health. 2021;20(1):63. · DOI
  156. Bloom MS, et al. Association between gestational PFAS exposure and Children’s adiposity in a diverse population. Environ Res. 2022;203: 111820. · DOI
  157. Chang C-J, et al. Per- and polyfluoroalkyl substance (PFAS) exposure, maternal metabolomic perturbation, and fetal growth in African American women: a meet-in-the-middle approach. Environ Int. 2022;158: 106964. · DOI · Paper page
  158. Geiger SD, et al. PFAS exposure and overweight/obesity among children in a nationally representative sample. Chemosphere. 2021;268: 128852. · DOI · Paper page
  159. Yan D, et al. Endocrine-disrupting chemicals and the risk of gestational diabetes mellitus: a systematic review and meta-analysis. Environ Health. 2022;21(1):53. · DOI · Paper page

Cited by

See all 91

Metadata

Authors
McAdam, J., & Bell, E. M.
Venue
Environmental Health
Published
2023-05-10
Volume
22
Issue
1
Pages
41-41
ISSN
1476-069X (ISSN-L)
OpenAlex
W4376133281
Cited by
91
References
31
FWCI
7.46
Type
journal article
Language
en
Open access
gold
Licence
Funders
Centers for Disease Control and Prevention (U01TS000303)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Determinants of maternal and neonatal PFAS concentrations: a review. https://app.cochat.ai/papers/10.1186/s12940-023-00992-x
The paper
McAdam, J., & Bell, E. M. (2023). Determinants of maternal and neonatal PFAS concentrations: a review. Environmental Health. https://doi.org/10.1186/s12940-023-00992-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.